Hemodynamic support in high-risk percutaneous coronary interventions and cardiogenic shock

2012 ◽  
Vol 4 (1) ◽  
pp. 125-136 ◽  
Author(s):  
Claudia A Martinez ◽  
Apurva O Badheka ◽  
William W O’Neill
Keyword(s):  
High Risk ◽  
Cardiogenic Shock ◽  
Percutaneous Coronary Interventions ◽  
Hemodynamic Support ◽  
Coronary Interventions ◽  
Percutaneous Coronary

scholarly journals THE USE OF HEMODYNAMIC SUPPORT IN OCTOGENERIAN PATIENTS DURING HIGH RISK PERCUTANEOUS CORONARY INTERVENTIONS

2014 ◽  
Vol 63 (12) ◽  
pp. A1897
Author(s):  
Ghassan Fraij ◽  
Joseph Massaro ◽  
Shukri David ◽  
Neal Kleiman ◽  
Ali Denktas ◽  
...  
Keyword(s):  
High Risk ◽  
Percutaneous Coronary Interventions ◽  
Hemodynamic Support ◽  
Coronary Interventions ◽  
Percutaneous Coronary

scholarly journals Utilization of Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock Complicating Acute Myocardial Infarction and High-Risk Percutaneous Coronary Interventions

2019 ◽  
Vol 8 (8) ◽  
pp. 1209 ◽  
Author(s):  
Asleh ◽  
Resar
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
High Risk ◽  
Cardiogenic Shock ◽  
Mechanical Circulatory Support ◽  
Left Ventricular ◽  
Circulatory Support ◽  
Percutaneous Coronary Interventions ◽  
Coronary Interventions ◽  
Percutaneous Coronary

Given the tremendous progress in interventional cardiology over the last decade, a growing number of older patients, who have more comorbidities and more complex coronary artery disease, are being considered for technically challenging and high-risk percutaneous coronary interventions (PCI). The success of performing such complex PCI is increasingly dependent on the availability and improvement of mechanical circulatory support (MCS) devices, which aim to provide hemodynamic support and left ventricular (LV) unloading to enable safe and successful coronary revascularization. MCS as an adjunct to high-risk PCI may, therefore, be an important component for improvement in clinical outcomes. MCS devices in this setting can be used for two main clinical conditions: patients who present with cardiogenic shock complicating acute myocardial infarction (AMI) and those undergoing technically complex and high-risk PCI without having overt cardiogenic shock. The current article reviews the advancement in the use of various devices in both AMI complicated by cardiogenic shock and complex high-risk PCI, highlights the available hemodynamic and clinical data associated with the use of MCS devices, and presents suggestive management strategies focusing on appropriate patient selection and optimal timing and support to potentially increase the clinical benefit from utilizing these devices during PCI in this high-risk group of patients.

Sign in / Sign up

Export Citation Format

Share Document